Breast Cancer Research

official impact factor 5.79

HER2 therapy. Small molecule HER-2 tyrosine kinase inhibitors

Neil Spector*, Wenle Xia, Iman El-Hariry, Yossi Yarden and Sarah Bacus

Breast Cancer Research 2007, 9:205 doi:10.1186/bcr1652

Accesses  

  • Last 30 days: 106 accesses
  • Last 365 days: 1373 accesses
  • All time: 8329 accesses

Cited by

BioMed Central: 1 citation

Commentary   Free

Transphosphorylation of kinase-dead HER3 and breast cancer progression: a new standpoint or an old concept revisited?

Javier A Menendez, Ruth Lupu Breast Cancer Research 2007, 9:111 (19 October 2007)